Stereotaxis to Present at the Deutsche Bank 33rd Annual Health Care Conference
Attendance at the conference is by invitation only. The audiopresentation will be webcast live and remain available for 90 days athttp://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=STXS&item_id=1827565.
Stereotaxis designs, manufactures and markets an advanced cardiologyinstrument control system for use in a hospital's interventional surgicalsuite to enhance the treatment of coronary artery disease and arrhythmias.The Stereotaxis System is designed to enable physicians to complete morecomplex interventional procedures by providing image guided delivery ofcatheters and guidewires through the blood vessels and chambers of the heartto treatment sites. This is achieved using computer-controlled, externallyapplied magnetic fields that govern the motion of the working tip of thecatheter or guidewire, resulting in improved navigation, shorter proceduretime and reduced x-ray exposure. The core components of the Stereotaxissystem have received regulatory clearance in the U.S., Europe and Canada.
SOURCE Stereotaxis, Inc.
You May Also Like